CN Patent

CN101301306A — Dft在制备治疗和预防休克药物中的应用

Assigned to GUANGDONG TIANPU BIOCHEMICAL MEDICINE CO Ltd · Expires 2008-11-12 · 18y expired

What this patent protects

本发明涉及DFT(Defibrotide)用于制备治疗和预防休克的药物用途及按该方法制备的药物组合物。本发明的药物组合物对休克有明显的治疗和预防作用。本发明的药物组合物通常以冻干粉针剂、注射液剂或胶囊的形式使用。

USPTO Abstract

本发明涉及DFT(Defibrotide)用于制备治疗和预防休克的药物用途及按该方法制备的药物组合物。本发明的药物组合物对休克有明显的治疗和预防作用。本发明的药物组合物通常以冻干粉针剂、注射液剂或胶囊的形式使用。

Drugs covered by this patent

Patent Metadata

Patent number
CN101301306A
Jurisdiction
CN
Classification
—
Expires
2008-11-12
Drug substance claim
No
Drug product claim
No
Assignee
GUANGDONG TIANPU BIOCHEMICAL MEDICINE CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.